Estrogen-mediated downregulation of HIF-1α signaling in B lymphocytes influences postmenopausal bone loss

Abstract

In the bone marrow, B cells and bone-resorbing osteoclasts colocalize and form a specific microenvironment. How B cells functionally influence osteoclasts and bone architecture is poorly understood. Using genetically modified mice and high-throughput analyses, we demonstrate that prolonged HIF-1α signaling in B cells leads to enhanced RANKL production and osteoclast formation. In addition, deletion of HIF-1α in B cells prevents estrogen deficiency-induced bone loss in mice. Mechanistically, estrogen controls HIF-1α protein stabilization through HSP70-mediated degradation in bone marrow B cells. The stabilization of HIF-1α protein in HSP70-deficient bone marrow B cells promotes RANKL production and osteoclastogenesis. Induction of HSP70 expression by geranylgeranylacetone (GGA) administration alleviates ovariectomy-induced osteoporosis. Moreover, RANKL gene expression has a positive correlation with HIF1A expression in human B cells. In conclusion, HIF-1α signaling in B cells is crucial for the control of osteoclastogenesis, and the HSP70/HIF-1α axis may serve as a new therapeutic target for osteoporosis.

References

[1] Zaidi M. Skeletal remodeling in health and disease. Nat. Med., 2007, 13: 791-801

[2] Mellis DJ, Itzstein C, Helfrich MH, Crockett JC. The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption. J. Endocrinol., 2011, 211: 131-143

[3] Nakashima T, Takayanagi H. New regulation mechanisms of osteoclast differentiation. Ann. N. Y. Acad. Sci., 2011, 1240: E13-E18

[4] Ross FP. M-CSF, c-Fms, and signaling in osteoclasts and their precursors. Ann. N. Y. Acad. Sci., 2006, 1068: 110-116

[5] Devlin RD, Reddy SV, Savino R, Ciliberto G, Roodman GD. IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures. J. Bone Miner. Res., 1998, 13: 393-399

[6] Kobayashi K et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med., 2000, 191: 275-286

[7] Ma T et al. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Cytokine, 2004, 26: 138-144

[8] Wong PK et al. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum., 2006, 54: 158-168

[9] Pacifici R. Role of T cells in ovariectomy induced bone loss−revisited. J. Bone Miner. Res., 2012, 27: 231-239

[10] Walsh MC et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol., 2006, 24: 33-63

[11] Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J. Clin. Investig., 2014, 124: 466-472

[12] Chen X et al. Osteoblast-osteoclast interactions. Connect. Tissue Res., 2018, 59: 99-107

[13] Wu Y et al. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis. Arthritis Rheum., 2005, 52: 3257-3268

[14] Usui M et al. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J. Bone Miner. Res., 2008, 23: 314-325

[15] Hensel JA, Khattar V, Ashton R, Ponnazhagan S. Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations. Lab. Investig., 2019, 99: 93-106

[16] Aguila HL et al. Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice. J. Bone Miner. Res., 2012, 27: 1030-1042

[17] Li Y, Terauchi M, Vikulina T, Roser-Page S, Weitzmann MN. B cell production of both OPG and RANKL is significantly increased in aged mice. Open Bone J., 2014, 6: 8-17

[18] Li S et al. PKC-delta deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling. Cell Death Dis., 2020, 11: 762

[19] Titanji K. Beyond antibodies: B cells and the OPG/RANK-RANKL pathway in health, Non-HIV disease and HIV-induced bone loss. Front. Immunol., 2017, 8: 1851

[20] Onal M et al. Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J. Biol. Chem., 2012, 287: 29851-29860

[21] Xu S et al. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of beta-Catenin and RANKL/OPG. J. Bone Miner. Res., 2016, 31: 1320-1333

[22] Spencer JA et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature, 2014, 508: 269-273

[23] Regan JN et al. Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation. Proc. Natl. Acad. Sci. USA, 2014, 111: 8673-8678

[24] Ivan M et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 2001, 292: 464-468

[25] Jaakkola P et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 2001, 292: 468-472

[26] Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell, 2010, 40: 294-309

[27] Luo W et al. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J. Biol. Chem., 2010, 285: 3651-3663

[28] Barliya T, Mandel M, Livnat T, Weinberger D, Lavie G. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. PLoS One, 2011, 6: e22849

[29] Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat. Rev. Mol. Cell Biol., 2013, 14: 630-642

[30] Hubbi ME et al. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J. Biol. Chem., 2013, 288: 10703-10714

[31] Liu YV et al. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol. Cell, 2007, 25: 207-217

[32] Heng TS, Painter MW Immunological Genome Project, C. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol., 2008, 9: 1091-1094

[33] Akerfelt M, Morimoto RI, Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol., 2010, 11: 545-555

[34] Buch T et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods, 2005, 2: 419-426

[35] Unoshima M et al. Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection. Antimicrobial Agents Chemother., 2003, 47: 2914-2921

[36] Suzuki S et al. Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int., 2005, 67: 2210-2220

[37] Fujibayashi T et al. Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model. BMC Pulm. Med., 2009, 9

[38] Kraus H et al. A feeder-free differentiation system identifies autonomously proliferating B cell precursors in human bone marrow. J. Immunol., 2014, 192: 1044-1054

[39] Xiao P et al. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J. Bone Miner. Res., 2008, 23: 644-654

[40] Tawfeek H et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS One, 2010, 5: e12290

[41] Hartgring SA, Willis CR, Bijlsma JW, Lafeber FP, van Roon JA. Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res. Ther., 2012, 14: R137

[42] Grotsch B et al. Fra1 controls rheumatoid factor autoantibody production by bone marrow plasma cells and the development of autoimmune bone loss. J. Bone Miner. Res., 2019, 34: 1352-1365

[43] Jarry CR et al. Secreted osteoclastogenic factor of activated T cells (SOFAT), a novel osteoclast activator, in chronic periodontitis. Hum. Immunol., 2013, 74: 861-866

[44] Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem. Med., 2013, 23: 43-63

[45] Amarasekara DS et al. Regulation of osteoclast differentiation by cytokine networks. Immune Netw., 2018, 18: e8

[46] Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone, 2010, 47: 472-479

[47] Cheung LC et al. New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment. Leukemia, 2018, 32: 2326-2338

[48] Burrows N et al. Dynamic regulation of hypoxia-inducible factor-1alpha activity is essential for normal B cell development. Nat. Immunol., 2020, 21: 1408-1420

[49] Hang K et al. Role of the heat shock protein family in bone metabolism. Cell Stress Chaperones, 2018, 23: 1153-1164

[50] Tanaka K, Mizushima T. Protective role of HSF1 and HSP70 against gastrointestinal diseases. Int. J. Hyperthermia, 2009, 25: 668-676

[51] Choudhry H, Harris AL. Advances in hypoxia-inducible factor biology. Cell Metab., 2018, 27: 281-298

[52] Lujan, D. A., Ochoa, J. L. & Hartley, R. S. Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip. Rev. RNA 9, https://doi.org/10.1002/wrna.1462 (2018).

[53] Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res., 2006, 66: 2576-2583

[54] Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J., 1998, 17: 3005-3015

[55] Hobeika E et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA, 2006, 103: 13789-13794

[56] Strom, J. O., Theodorsson, A., Ingberg, E., Isaksson, I. M. & Theodorsson, E. Ovariectomy and 17beta-estradiol replacement in rats and mice: a visual demonstration. J. Vis. Exp. 64, e4013 (2012).

[57] Adam, S. et al. JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function. Sci. Transl. Med. 12, eaay4447 (2020).

[58] Luo Y et al. Microbiota from obese mice regulate hematopoietic stem cell differentiation by altering the bone niche. Cell Metab., 2015, 22: 886-894

[59] Calderon-Gomez E et al. Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur. J. Immunol., 2011, 41: 1696-1708

[60] Meng X et al. Hypoxia-inducible factor-1alpha is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat. Commun., 2018, 9